81 FR 43611 - Center for Substance Abuse Prevention; Advisory Committee; Drug Testing Advisory Board; Renewal
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration Federal Register Volume 81, Issue 128 (July 5, 2016)
Substance Abuse and Mental Health Services Administration
Federal Register Volume 81, Issue 128 (July 5, 2016)
| Page Range | 43611-43611 | |
| FR Document | 2016-15815 |
[Federal Register Volume 81, Number 128 (Tuesday, July 5, 2016)] [Notices] [Page 43611] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-15815] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Advisory Committee; Drug Testing Advisory Board; Renewal AGENCY: Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Substance Abuse and Mental Health Services Administration (SAMHSA) is announcing the renewal of SAMHSA's Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB). FOR FURTHER INFORMATION CONTACT: Brian Makela, Division of Workplace Programs, CSAP, SAMHSA, 5600 Fishers Lane, Room 16N02B, Rockville, Maryland 20857, Telephone: 240-276-2600, Fax: 240-276-2610, Email: [email protected]. SUPPLEMENTARY INFORMATION: The Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB) is authorized by 42 U.S.C. 217a (Section 222 of the Public Health Service Act), as amended. The CSAP DTAB is governed by the provisions of the Federal Advisory Committee Act, as amended, 5 U.S.C., App., which sets forth standards for the formation and use of advisory committees. The CSAP DTAB provides advice to the Administrator, SAMHSA, based on an ongoing review of the direction, scope, balance, and emphasis of the Agency's drug testing activities and the drug testing laboratory certification program. Summer King, Statistician, Substance Abuse and Mental Health Services Administration. [FR Doc. 2016-15815 Filed 7-1-16; 8:45 am] BILLING CODE 4162-20-P
![Federal Register / Vol. 81, No. 128 / Tuesday, July 5, 2016 / Notices 43611
Time: 1:00 p.m. to 4:00 p.m. (Catalogue of Federal Domestic Assistance Dated: June 28, 2016.
Agenda: To review and evaluate contract Program Nos. 93.213, Research and Training Michelle Trout,
proposals. in Complementary and Integrative Health,
Place: National Institutes of Health, 6710 B National Institutes of Health, HHS) Program Analyst, Office of Federal Advisory
Rockledge Drive, Room 2131D, Bethesda, MD Committee Policy.
Dated: June 28, 2016. [FR Doc. 2016–15732 Filed 7–1–16; 8:45 am]
20892 (Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy, Michelle Trout,
BILLING CODE 4140–01–P
Ph.D., Scientific Review Officer, Division of Program Analyst, Office of Federal Advisory
Scientific Review, Eunice Kennedy Shriver Committee Policy.
National Institute of Child Health and [FR Doc. 2016–15734 Filed 7–1–16; 8:45 am] DEPARTMENT OF HEALTH AND
Human Development, NIH, 6710 B Rockledge
Drive, Room 2131D, Bethesda, MD 20892,
BILLING CODE 4140–01–P HUMAN SERVICES
(301) 435–6680, skandasa@mail.nih.gov.
Substance Abuse and Mental Health
(Catalogue of Federal Domestic Assistance DEPARTMENT OF HEALTH AND
Program Nos. 93.864, Population Research; Services Administration
HUMAN SERVICES
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Center for Substance Abuse
National Institutes of Health Prevention; Advisory Committee; Drug
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
National Heart, Lung, and Blood Testing Advisory Board; Renewal
Institutes of Health, HHS)
Institute; Notice of Meeting
Dated: June 28, 2016. AGENCY: Substance Abuse and Mental
Michelle Trout, Pursuant to section 10(a) of the Health Services Administration, HHS.
Program Analyst, Office of Federal Advisory Federal Advisory Committee Act, as ACTION: Notice.
Committee Policy. amended (5 U.S.C. App.), notice is
[FR Doc. 2016–15731 Filed 7–1–16; 8:45 am] hereby given of a meeting of the Sleep SUMMARY: The Substance Abuse and
BILLING CODE 4140–01–P Disorders Research Advisory Board. The Mental Health Services Administration
meeting will be open to the public, with (SAMHSA) is announcing the renewal
attendance limited to space available. of SAMHSA’s Center for Substance
DEPARTMENT OF HEALTH AND Individuals who plan to attend and Abuse Prevention (CSAP) Drug Testing
HUMAN SERVICES need special assistance, such as sign
Advisory Board (DTAB).
language interpretation or other
National Institutes of Health reasonable accommodations, should FOR FURTHER INFORMATION CONTACT:
notify the Contact Person listed below Brian Makela, Division of Workplace
National Center for Complementary & in advance of the meeting. Programs, CSAP, SAMHSA, 5600
Integrative Health; Notice of Closed
Name of Committee: Sleep Disorders Fishers Lane, Room 16N02B, Rockville,
Meeting Research Advisory Board. Maryland 20857, Telephone: 240–276–
Pursuant to section 10(d) of the Date: August 18–19, 2016. 2600, Fax: 240–276–2610, Email:
Federal Advisory Committee Act, as Time: August 18, 2016, 1:00 p.m. to 5:00 brian.makela@ssamhsa.hhs.gov.
p.m.
amended (5 U.S.C. App.), notice is
Agenda: To discuss plans for the proposed SUPPLEMENTARY INFORMATION: The
hereby given of the following meeting. revision of the NIH Sleep Disorders Research
The meeting will be closed to the Center for Substance Abuse Prevention
Plan, and potential directions for inter- (CSAP) Drug Testing Advisory Board
public in accordance with the agency coordination activities.
provisions set forth in sections Place: National Institutes of Health, Two (DTAB) is authorized by 42 U.S.C. 217a
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Rockledge Center, Conference Room 9112/ (Section 222 of the Public Health
as amended. The grant applications and 9116, 6701 Rockledge Drive, Bethesda, MD Service Act), as amended. The CSAP
the discussions could disclose 20892–7952. DTAB is governed by the provisions of
confidential trade secrets or commercial Time: August 19, 2016, 8:00 a.m. to 3:00 the Federal Advisory Committee Act, as
p.m. amended, 5 U.S.C., App., which sets
property such as patentable material,
Agenda: To discuss plans for the proposed
and personal information concerning revision of the NIH Sleep Disorders Research
forth standards for the formation and
individuals associated with the grant Plan, and potential directions for inter- use of advisory committees.
applications, the disclosure of which agency coordination activities. The CSAP DTAB provides advice to
would constitute a clearly unwarranted Place: National Institutes of Health, Two the Administrator, SAMHSA, based on
invasion of personal privacy. Rockledge Center Conference Room 9112/
an ongoing review of the direction,
Name of Committee: National Center for 9116, 6701 Rockledge Drive, Bethesda, MD
20892–7952. scope, balance, and emphasis of the
Complementary and Integrative Health
Special Emphasis Panel; Clinical Research on Contact Person: Michael J. Twery, Ph.D., Agency’s drug testing activities and the
Mind-Body Interventions. Director, National Center on Sleep Disorders drug testing laboratory certification
Date: July 29, 2016. Research, Division of Lung Diseases, National program.
Time: 12:00 p.m. to 4:00 p.m. Heart, Lung, and Blood Institute, National
Agenda: To review and evaluate grant Institutes of Health, 6701 Rockledge Drive, Summer King,
applications. Suite 10038, Bethesda, MD 20892–7952, 301– Statistician, Substance Abuse and Mental
Place: National Institutes of Health, DEMII, 435–0199, twerym@nhlbi.nih.gov. Health Services Administration.
401, 6707 Democracy Blvd., Bethesda, MD (Catalogue of Federal Domestic Assistance [FR Doc. 2016–15815 Filed 7–1–16; 8:45 am]
sradovich on DSK3GDR082PROD with NOTICES
20892 (Virtual Meeting). Program Nos. 93.233, National Center for
BILLING CODE 4162–20–P
Contact Person: Hungyi Shau, Ph.D., Sleep Disorders Research; 93.837, Heart and
Scientific Review Officer, National Center for Vascular Diseases Research; 93.838, Lung
Complementary and Integrative Health, Diseases Research; 93.839, Blood Diseases
National Institutes of Health, 6707 and Resources Research, 93.840 Translation
Democracy Boulevard, Suite 401, Bethesda, and Implementation Science for Heart, Lung,
MD 20892, 301–480–9504, Hungyi.Shau@ Blood Diseases, and Sleep Disorders,
nih.gov. National Institutes of Health, HHS)
VerDate Sep<11>2014 17:27 Jul 01, 2016 Jkt 238001 PO 00000 Frm 00042 Fmt 4703 Sfmt 9990 E:\FR\FM\05JYN1.SGM 05JYN1](https://thefederalregister.org/doc/81_FR_43739/page/1.svg)
Document Created: 2016-07-01 23:49:59
Document Modified: 2016-07-01 23:49:59
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | Brian Makela, Division of Workplace Programs, CSAP, SAMHSA, 5600 Fishers Lane, Room 16N02B, Rockville, Maryland 20857, Telephone: 240-276-2600, Fax: 240-276-2610, Email: [email protected] | |
| FR Citation | 81 FR 43611 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR